Abstract | BACKGROUND: METHODS: ICR mice were divided into 5 groups: 70% HTx, 85% HTx, 85% HTx plus ONO-SM362, 85% HTx plus monoclonal TNF-alpha antibody (mAb), and 85% HTx plus FR167653, a TNF-alpha inhibitor. We analyzed the survival rate, blood ammonia (NH(3)), serum TNF-alpha levels, TNF-alpha mRNA expression in the liver and spleen by real-time polymerase chain reaction, histologic changes, polymorphonuclear neutrophils (PMNs) infiltration, and proliferating cell nuclear antigen labeling index ( PCNA LI) in the 5 groups. RESULTS: The survival rate at 7 days after surgery was 100%, 0%, 100%, 50%, and 0%, for the 70% HTx, 85% HTx, 85% HTx + ONO-SM362, 85% HTx + mAb, and 85% HTx + FR167653, respectively. Mice that underwent 85% HTx died from liver failure associated with a significant rise in serum TNF-alpha level. ONO-SM362 and mAb improved animal survival and enhanced PCNA LI. In addition, ONO-SM362 inhibited TNF-alpha mRNA expression in the remnant liver and suppressed PMNs infiltration. CONCLUSIONS:
|
Authors | Toshiro Ogata, Kenichiro Yamashita, Hiroyuki Horiuchi, Koji Okuda, Satoru Todo |
Journal | Surgery
(Surgery)
Vol. 143
Issue 4
Pg. 545-55
(Apr 2008)
ISSN: 1532-7361 [Electronic] United States |
PMID | 18374053
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- (1S,2R)-2-hexyloxy carbonylamino-1 methyl-2-(3-methoxyphenyl) ethyl disodium phosphate
- Anti-Inflammatory Agents
- Organophosphorus Compounds
- Tumor Necrosis Factor-alpha
|
Topics |
- Animals
- Anti-Inflammatory Agents
(pharmacology)
- Disease Models, Animal
- Hepatectomy
(adverse effects)
- Liver Failure
(etiology, mortality, prevention & control)
- Liver Regeneration
(drug effects)
- Male
- Mice
- Mice, Inbred ICR
- Organophosphorus Compounds
(pharmacology, therapeutic use)
- Survival Analysis
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
|